Cell MedX Corp.
CMXC · OTC
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | -54.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | 17.5% | 66.5% |
| EBITDA | $0 | $0 | -$0 | -$0 |
| % Margin | – | – | -16,166.3% | -11,056% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -17,923.3% | -11,498.4% |
| EPS Diluted | -0.03 | -0.003 | -0.008 | -0.011 |
| % Growth | -782.4% | 57% | 28.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |